Trial
NCT03883360
Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
Sheppard Pratt Health System; University of California, Los Angeles
Condition
Schizophrenia Spectrum Disorders
Intervention
Cannabidiol (CBD)
Why stopped
not funded
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-19